Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01996865
Brief Title: Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. (MAGNIFY)

First Submitted : November 22, 2013
First Submitted that Met QC Criteria : November 22, 2013
First Posted : November 27, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : March 25, 2021
Last Update Posted : March 26, 2021